The β‐catenin pathway contributes to the effects of leptin on SREBP‐1c expression in rat hepatic stellate cells and liver fibrosis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Liver fibrosis is commonly associated with obesity and most obese patients develop hyperleptinaemia. The adipocytokine leptin has a unique role in the development of liver fibrosis. Activation of hepatic stellate cells (HSCs) is a key step in hepatic fibrogenesis and sterol regulatory element‐binding protein‐1c (SREBP‐1c) can inhibit HSC activation. We have shown that leptin strongly inhibits SREBP‐1c expression in rat HSCs. Hence, we aimed to clarify whether the β‐catenin pathway, the crucial negative regulator of adipocyte differentiation, mediates the effects of leptin on SREBP‐1c expression in HSCs and in mouse liver fibrosis. Experimental Approach: HSCs were prepared from rats and mice. Gene expressions were analysed by real‐time PCR, W estern blot analysis, immunostaining and transient transfection assays. Key Results: Leptin increased β‐catenin protein but not mRNA levels in cultured HSC s. Leptin induced phosphorylation of glycogen synthase kinase‐3β at Ser 9 and subsequent stabilization of β‐catenin protein was mediated, at least in part, by ERK and p38 MAPK pathways. The leptin‐induced β‐catenin pathway reduced SREBP‐1c expression and activity but did not affect protein levels of key regulators controlling SREBP‐1c activity, and was not involved in leptin inhibition of liver X receptor α. In a mouse model of liver injury, the β‐catenin pathway was shown to be involved in leptin‐induced liver fibrosis. Conclusions and Implications: The β‐catenin pathway contributes to leptin regulation of SREBP‐1c expression in HSCs and leptin‐induced liver fibrosis in mice. These results have potential implications for clarifying the mechanisms of liver fibrogenesis associated with elevated leptin levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843 · cited 1×
“While we were preparing this article, Akhmetshina and his colleagues found that b-catenin activity was correlated with transforming growth factor-b1(TGF-b1)-induced dermal fibrosis (Akhmetshina et al., 2012).”
MethodSaxena, N. K., Ikeda, K., Rockey, D. C., Friedman, S. L., & Anania, F. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32029 · Cited by 382 · cited 1×
“It appears that leptin can directly target HSCs via activation of its receptor and stimulate HSC activation and fibrogenesis (Saxena et al., 2002; Bertolani and Marra, 2010).”
BackgroundWnt signaling mediates regional specification in the vertebrate face
Brugmann, S. A., Goodnough, L. H., Gregorieff, A., Leucht, P., ten Berge, D., Fuerer, C., Clevers, H., Nusse, R., & Helms, J. A. (2007) · Development · doi:10.1242/dev.005132 · Cited by 213 · cited 1×
“Dkk-1 [adenovirus encoding mouse Dickkopf-1 (Brugmann et al., 2007)] or Ad.”
Garza, J. C., Guo, M., Zhang, W., & Lu, X.-Y. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.161 · Cited by 209
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target
Lam, A. P., & Gottardi, C. J. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834b3309 · Cited by 191
Cited by
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
Leptin in nonalcoholic fatty liver disease: A narrative review
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.012 · Cited by 235
Qiao, H., Zhou, Y., Qin, X., Cheng, J., He, Y., & Jiang, Y. (2018) · Stem Cells International · doi:10.1155/2018/1239143 · Cited by 28
“SYP can be used as a marker for quiescent and activated HSCs [23].”
BackgroundSelf-citation
Metadata
- Authors
- Zhai, X., Yan, K., Fan, J., Niu, M., Zhou, Q., Zhou, Y., Chen, H., & Zhou, Y.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-04-12
- Volume
- 169
- Issue
- 1
- Pages
- 197-212
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1544118687
- Cited by
- 69
- References
- 9
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The β‐catenin pathway contributes to the effects of leptin on SREBP‐1c expression in rat hepatic stellate cells and liver fibrosis. https://app.cochat.ai/papers/10.1111/bph.12114
- The paper
- Zhai, X., Yan, K., Fan, J., Niu, M., Zhou, Q., Zhou, Y., Chen, H., & Zhou, Y. (2013). The β‐catenin pathway contributes to the effects of leptin on SREBP‐1c expression in rat hepatic stellate cells and liver fibrosis. British Journal of Pharmacology. https://doi.org/10.1111/bph.12114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.